Anteris Technologies Global Corp. (AVR) Revenue Growth
Anteris Technologies Global Corp. (AVR) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2023-12-31 | -99.94% |
| 2024-12-31 | -1.17% |
| 2025-12-31 | 70673.21% |
How AVR compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| AKBA | Akebia Therapeutics Inc. | 47.46% |
| HROW | Harrow Inc Com | 36.41% |
| RARE | Ultragenyx Pharmaceutical Inc. | 20.18% |
| ADMA | ADMA Biologics Inc | 19.63% |
| NTLA | Intellia Therapeutics Inc. | 16.92% |
These are five companies in the same sector as AVR with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Anteris Technologies Global Corp. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("AVR", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | AVR | $8.74 | -2.56% | 0.53M |
| 3 | ||||
| 4 | ||||
| 5 |